Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial

NCT04839354 is registered in ClinicalTrials.gov with Claudia R. Morris as lead sponsor.

NCT NCT04839354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04839354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial
Lead sponsor
Claudia R. Morris
Phase
Phase 3
Overall status
Completed
Start date
June 21, 2021
Completion date
July 11, 2024
Enrollment
271 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease